Bai Ao Tai: The company's clinical trial application for the investigational drugs BAT8008 combined with BAT1006 and trastuzumab for the treatment of HER2-positive advanced solid tumors has been approved.

2026-04-13 11:43:33

BaiAoTai Announcement: The company recently received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration. The company’s investigational drugs BAT8008 in combination with BAT1006 and Trastuzumab for the treatment of HER2-positive advanced solid tumors have been approved for clinical trial application.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
Gate13thAnniversaryDr.HanLetter
37.77K Popularity
#
CryptoMarketsDipSlightly
169.66K Popularity
#
USBlocksStraitofHormuz
709.05K Popularity
#
AaveDAOApproves$25MGrant
1.8M Popularity
#
GateSquareAprilPostingChallenge
1.62M Popularity

Sitemap

Bai Ao Tai: The company's clinical trial application for the investigational drugs BAT8008 combined with BAT1006 and trastuzumab for the treatment of HER2-positive advanced solid tumors has been approved.

Trending Topics

Gate13thAnniversaryDr.HanLetter

CryptoMarketsDipSlightly

USBlocksStraitofHormuz

AaveDAOApproves$25MGrant

GateSquareAprilPostingChallenge

Pin